Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Tenax Therapeutics Secures European Patent Protection For Levosimendan In PH-HFpEF Through 2040, Supporting Phase 3 LEVEL-2 Trial And Global IP Expansion

Author: Benzinga Newsdesk | September 16, 2025 07:11am

Posted In: TENX